Source link : https://www.yourblogdomain.com/2024/10/25/everest-medicines-announces-taiwan-tfda-approval-of-nefecon-for-the-treatment-of-primary-iga-nephropathy/
Source link : https://news7.asia/news/everest-medicines-announces-taiwan-tfda-approval-of-nefecon-for-the-treatment-of-primary-iga-nephropathy/ SHANGHAI, Oct 21, 2024 – (ACN Newswire) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announces that the Taiwan Food and Drug Administration (TFDA) has approved NEFECON® indicated “to reduce the loss of kidney […]
Author : yourblogdomain
Publish date : 2024-10-25 05:04:42
Copyright for syndicated content belongs to the linked Source.
inNews